LSD1 inhibition: a therapeutic strategy in cancer?

Author： Lynch James T Harris William J Somervaille Tim C P

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.12, 2012-12, pp. : 1239-1249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic strategy for breast cancer: mammalian target of rapamycin inhibition

By Yip Adrian Yun-San Ong Eleanor Yuen-Yuen Chow Louis Wing-Cheong

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 457-466

Informa Healthcare

Access to resources Recommend Favorite

Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2179-2188

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of &bgr;-amyloid formation as a therapeutic strategy

By Moore C.L. Wolfe M.S.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 135-146

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-04 ,pp. : 563-578

Bentham Science Publishers

Access to resources Recommend Favorite

MiRNA-based Therapeutic Strategy in Lung Cancer

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 6011-6018

Bentham Science Publishers

Access to resources Recommend Favorite